The development of oral vaccines based on live attenuated Salmonella strains

S. Chatfield, M. Roberts, P. Londono, I. Cropley, G. Douce, G. Dougan

Research output: Contribution to journalArticleResearchpeer-review

37 Citations (Scopus)


Safe, live attenuated Salmonella strains can be produced by introducing defined non-reverting mutations into the chromosome. Such rationally attenuated strains have proved to be excellent oral vaccines in several animal species and can therefore be considered as candidate vaccines against invasive salmonellosis in both animals and man. A panel of attenuating lesions is now available from which it is possible to tailor the level of attenuation and hence produce strains with different immunogenic properties. Because of the spectrum of immune responses produced by such Salmonella vaccine strains they have been utilised extensively as vectors for delivering heterologous antigens to the mammalian immune system. We have focussed on the development of a single dose oral tetanus vaccine based on attenuated Salmonella strains expressing a non-toxic, immunogenic protein derived from tetanus toxin (fragment C). Several different expression systems have been used for fragment C and candidate vaccine strains have been constructed that are capable of protecting orally immunised mice against a lethal challenge with tetanus toxin. An oral tetanus vaccine may help to reduce the mortality rate from tetanus in the developing world by overcoming the problems associated with the implementation of vaccine programmes using the current parenteral vaccine.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalFEMS Immunology and Medical Microbiology
Issue number1
Publication statusPublished - 1 Jan 1993
Externally publishedYes


  • Attenuation
  • Live vaccine
  • Oral tetanus vaccine
  • Salmonella sp.

Cite this